Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
Condition(s):Breast Cancer; OsteoporosisLast Updated:November 29, 2012Withdrawn
Hide Studies Not Open or Pending
Condition(s):Breast Cancer; OsteoporosisLast Updated:November 29, 2012Withdrawn
Condition(s):Breast CancerLast Updated:April 14, 2022Completed
Condition(s):Breast CancerLast Updated:October 5, 2018Completed
Condition(s):Breast Cancer; Psychosocial Effects of Cancer and Its TreatmentLast Updated:January 7, 2013Completed
Condition(s):Breast CancerLast Updated:June 26, 2013Completed
Condition(s):Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation TherapyLast Updated:August 1, 2016Completed
Condition(s):Breast CancerLast Updated:October 12, 2015Completed
Condition(s):DCIS; Breast Cancer; Low Risk DCIS; Breast Conserving Surgery; Radiotherapy OmissionLast Updated:December 12, 2023Recruiting
Condition(s):DCIS; Breast Carcinoma in Situ; CalcificationLast Updated:January 22, 2024Not yet recruiting
Condition(s):Invasive Breast Cancer (Stage I-III); Ductal Carcinoma in Situ; Lobular Carcinoma in Situ; Lobular Carcinoma; Fatigue Related to Cancer TreatmentLast Updated:November 16, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.